Clinical Trial Update: Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tamibarotene in combination with venetoclax and azacitidine in newly diagnosed acute myeloid leukemia has been terminated; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Tamibarotene (tamibarotene)
• Venetoclax (venetoclax)

Snippet

Sponsor: Syros Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2025-02-24